Name
osaühing PÕLVA APTEEK
Registry code
10062841
VAT number
EE100626410
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
31.07.1996 (28)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
47731 - Dispensing chemist in specialised stores
3 322 204 €
158 397 €
5%
1 874 €
(estimate is approximate)
973 836 €
11
Submitted
No tax arrears
16%
11%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Kaja Lilium 08.12.1955 (68) | 100% - 2 556.00 EUR | Board member (chairman) | Direct ownership |
| 2019 06.10.2020 | 2020 07.06.2021 | 2021 09.06.2022 | 2022 20.06.2023 | 2023 21.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 1 603 763 € | 2 327 048 € | 2 597 431 € | 3 193 336 € | 3 322 204 € |
| Net profit (loss) for the period | 97 939 € | 199 093 € | 188 905 € | 168 920 € | 158 397 € |
| Profit Margin | 6% | 9% | 7% | 5% | 5% |
| Current Assets | 627 797 € | 869 677 € | 1 156 641 € | 1 150 059 € | 1 333 915 € |
| Fixed Assets | 40 526 € | 48 028 € | 46 733 € | 150 202 € | 84 334 € |
| Total Assets | 668 323 € | 917 705 € | 1 203 374 € | 1 300 261 € | 1 418 249 € |
| Current Liabilities | 269 802 € | 320 091 € | 416 855 € | 424 822 € | 444 413 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 398 521 € | 597 614 € | 786 519 € | 875 439 € | 973 836 € |
| Employees | 9 | 10 | 11 | 10 | 11 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 851 136.1 € | 55 044.49 € | 39 238.89 € | 15 |
| 2023 Q4 | 883 473.23 € | 45 189.35 € | 32 131.9 € | 13 |
| 2023 Q3 | 852 667.17 € | 55 656.19 € | 31 348.56 € | 13 |
| 2023 Q2 | 801 464.28 € | 41 847.82 € | 30 263.13 € | 13 |
| 2023 Q1 | 841 497.45 € | 55 358.85 € | 39 002.05 € | 12 |
| 2022 Q4 | 790 435.96 € | 55 139.71 € | 27 439.53 € | 12 |
| 2022 Q3 | 762 829.43 € | 40 020.21 € | 32 147.91 € | 11 |
| 2022 Q2 | 827 713.33 € | 50 187.48 € | 24 627.24 € | 12 |
| 2022 Q1 | 732 518.79 € | 33 993.03 € | 24 431.18 € | 11 |
| 2021 Q4 | 750 509.5 € | 34 002.7 € | 20 421.42 € | 11 |
| 2021 Q3 | 599 586.22 € | 33 934.25 € | 21 207.72 € | 10 |
| 2021 Q2 | 636 774.45 € | 32 238.36 € | 20 136.42 € | 10 |
| 2021 Q1 | 619 916.69 € | 37 038.5 € | 22 165.21 € | 10 |
| 2020 Q4 | 635 078.09 € | 26 600.11 € | 17 985.62 € | 10 |
| 2020 Q3 | 542 553.37 € | 29 080.27 € | 19 558.14 € | 10 |
| 2020 Q2 | 649 078.7 € | 32 632.88 € | 18 863.32 € | 9 |
| 2020 Q1 | 473 849.05 € | 32 143.3 € | 22 167.46 € | 9 |
